Application | Comment | Organism |
---|---|---|
medicine | knockdown of isoform PRMT5 results in more paralysis in a Caenorhabditis elegans model of Alzheimer's disease | Caenorhabditis elegans |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Caenorhabditis elegans | P46580 | isoform PRMT5 | - |
Homo sapiens | O14744 | - |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
SH-SY5Y cell | - |
Homo sapiens | - |
Synonyms | Comment | Organism |
---|---|---|
PRMT5 | - |
Homo sapiens |
General Information | Comment | Organism |
---|---|---|
physiological function | isoform PRMT5 is down-regulated by amyloid-beta in primary neurons and SH-SY5Y cells, and this is associated with the up-regulation of the PRMT5 target protein E2F-1. Knockdown of PRMT5 in SH-SY5Y cells over-expressing the Swedish mutant form of human amyloid-beta precursor protein causes activation of E2F-1/p53/Bax, NF-kappaB, and GSK-3beta pathways, which coincides with increased apoptosis. Co-depletion of E2F-1 reduces the activation of p53/Bax, NF-kappaB, and GSK-3beta, and limits cell apoptosis | Homo sapiens |
physiological function | knockdown of isoform PRMT5 results in more paralysis in a Caenorhabditis elegans model of Alzheimer's disease | Caenorhabditis elegans |